Could your own tumor cells beat cancer? new trial launches
NCT ID NCT06488950
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This early-stage study tests a treatment using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight advanced solid tumors. About 30 adults who have not responded to standard treatments will receive these cells along with chemotherapy. The main goal is to check safety and see if tumors shrink.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Third Affiliated Hospital of Naval Medical University
RECRUITINGShanghai, China
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.